Medexus Pharmaceuticals Inc. ( MEDXF) - Stock Earnings

MEDXF Upcoming earnings

Estimated EPS and revenue columns are available to paid members.

Date EPS (actual / est.) Revenue low (est.) Revenue (actual / est.) Revenue high (est.)
Aug. 18, 2026, midnight — / — /

MEDXF Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q3 -441110 USD 34.6 million USD
2025Q4 — USD 34.4 million USD
2026Q1 — USD 35.0 million USD
2026Q3 Est.
2026Q4 Est.

MEDXF Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2024 808430 USD 154.4 million USD
2025 6.9 million USD 149.0 million USD
2026 — USD 141.0 million USD
2026 Est.

MEDXF

Price: $3.64

52 week price:
1.80
3.68

Earnings Per Share: -0.02 USD

P/E Ratio: -114.50

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 114.3 million

Links: